BIAFW

bioAffinity Technologies, Inc. - Warrant (BIAFW)

About bioAffinity Technologies, Inc. - Warrant (BIAFW)

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Details

Daily high
$0.27
Daily low
$0.27
Price at open
$0.27
52 Week High
$2.90
52 Week Low
$0.12
Market cap
--
Dividend yield
0.00%
Volume
269
Avg. volume
4,385
P/E ratio
--

bioAffinity Technologies, Inc. - Warrant News

Details

Daily high
$0.27
Daily low
$0.27
Price at open
$0.27
52 Week High
$2.90
52 Week Low
$0.12
Market cap
--
Dividend yield
0.00%
Volume
269
Avg. volume
4,385
P/E ratio
--